Goldman Sachs’s Anavex Life Sciences AVXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.47M | Sell |
804,435
-68,533
| -8% | -$297K | ﹤0.01% | 4353 |
|
|
2025
Q4 | $3.11M | Buy |
872,968
+569,579
| +188% | +$3.49M | ﹤0.01% | 4200 |
|
|
2025
Q3 | $2.7M | Buy |
303,389
+9,609
| +3% | +$97.5K | ﹤0.01% | 4212 |
|
|
2025
Q2 | $2.71M | Sell |
293,780
-117,879
| -29% | -$1.01M | ﹤0.01% | 3940 |
|
|
2025
Q1 | $3.53M | Sell |
411,659
-126,882
| -24% | -$1.2M | ﹤0.01% | 3682 |
|
|
2024
Q4 | $5.78M | Sell |
538,541
-123,561
| -19% | -$950K | ﹤0.01% | 3308 |
|
|
2024
Q3 | $3.76M | Buy |
662,102
+204,939
| +45% | +$1.18M | ﹤0.01% | 3611 |
|
|
2024
Q2 | $1.93M | Sell |
457,163
-77,049
| -14% | -$312K | ﹤0.01% | 3952 |
|
|
2024
Q1 | $2.72M | Buy |
534,212
+267,639
| +100% | +$1.51M | ﹤0.01% | 3625 |
|
|
2023
Q4 | $2.48M | Buy |
266,573
+45,556
| +21% | +$314K | ﹤0.01% | 3758 |
|
|
2023
Q3 | $1.45M | Sell |
221,017
-99,183
| -31% | -$789K | ﹤0.01% | 4006 |
|
|
2023
Q2 | $2.6M | Sell |
320,200
-351,612
| -52% | -$3.01M | ﹤0.01% | 3672 |
|
|
2023
Q1 | $5.76M | Sell |
671,812
-31,093
| -4% | -$310K | ﹤0.01% | 2923 |
|
|
2022
Q4 | $6.51M | Buy |
702,905
+393,592
| +127% | +$4.2M | ﹤0.01% | 2950 |
|
|
2022
Q3 | $3.19M | Sell |
309,313
-48,547
| -14% | -$512K | ﹤0.01% | 3549 |
|
|
2022
Q2 | $3.58M | Sell |
357,860
-80,904
| -18% | -$766K | ﹤0.01% | 3501 |
|
|
2022
Q1 | $5.4M | Buy |
438,764
+58,299
| +15% | +$717K | ﹤0.01% | 3283 |
|
|
2021
Q4 | $6.6M | Buy |
380,465
+272,791
| +253% | +$5.18M | ﹤0.01% | 3143 |
|
|
2021
Q3 | $1.93M | Buy |
107,674
+17,557
| +19% | +$349K | ﹤0.01% | 4231 |
|
|
2021
Q2 | $2.06M | Sell |
90,117
-45,755
| -34% | -$678K | ﹤0.01% | 4179 |
|
|
2021
Q1 | $2.03M | Buy |
135,872
+101,457
| +295% | +$1.11M | ﹤0.01% | 3968 |
|
|
2020
Q4 | $186K | Buy |
34,415
+10,317
| +43% | +$54.4K | ﹤0.01% | 5112 |
|
|
2020
Q3 | $110K | Buy |
24,098
+2,611
| +12% | +$11.2K | ﹤0.01% | 5069 |
|
|
2020
Q2 | $106K | Sell |
21,487
-19,889
| -48% | -$75.2K | ﹤0.01% | 4977 |
|
|
2020
Q1 | $130K | Buy |
+41,376
| New | +$144K | ﹤0.01% | 4876 |
|
|
2018
Q4 | – | Sell |
-115,954
| Closed | -$317K | – | 5227 |
|
|
2018
Q3 | $317K | Sell |
115,954
-202,317
| -64% | -$571K | ﹤0.01% | 4685 |
|
|
2018
Q2 | $833K | Buy |
318,271
+283,145
| +806% | +$791K | ﹤0.01% | 4198 |
|
|
2018
Q1 | $97K | Buy |
+35,126
| New | +$99.3K | ﹤0.01% | 5297 |
|
|
2017
Q1 | – | Sell |
-10,384
| Closed | -$41K | – | 6743 |
|
|
2016
Q4 | $41K | Sell |
10,384
-7,543
| -42% | -$26.9K | ﹤0.01% | 6442 |
|
|
2016
Q3 | $65K | Sell |
17,927
-5,124
| -22% | -$21.6K | ﹤0.01% | 6385 |
|
|
2016
Q2 | $141K | Sell |
23,051
-32,889
| -59% | -$159K | ﹤0.01% | 5937 |
|
|
2016
Q1 | $274K | Buy |
+55,940
| New | +$246K | ﹤0.01% | 5344 |
|
Other funds holding AVXL
VCM
SF
VPM
